Autres langues LungLife AI, Inc.

Actions

Temps Différé London S.E. Autres places de cotation 08:59:59 14/05/2024			Varia. 5j.	Varia. 1 janv.
25,5 ^GBX	0,00%		-1,92%	-44,57%

05/04	Transcript : LungLife AI, Inc., 2023 Earnings Call, Apr 05, 2024
04/04	LungLife annonce des pertes réduites pour une année de "réalisations considérables"	AN

LungLife reports narrowed losses in year of "considerable achievement"	04/04
LungLife AI, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
LungLife AI, Inc. announced that it has received $0.31578 million in funding	22/03
Cindrigo seeks Croatian exploration licence extension	08/03
Beowulf raises funds for Kallak iron ore project	04/03
LungLife AI announces success in Validation of LungLB in multi-site, prospective clinical study	05/02
Stocks down amid disappointing manufacturing data	02/01
London stocks make largely soft start to 2024	02/01
LungLife AI Completes Validation Study for Lung Cancer Test	02/01
AIM WINNERS & LOSERS: LungLife AI soars on test; Plexus falls on deal	02/01
Lunglife shares soar after successful lung cancer diagnostic trials	02/01
New Year begins largely green amid slew of PMIs	02/01
LungLife AI Discloses Delay in Clinical Study of Lung Cancer Test Kit	28/09/23
LungLife AI LungLB clinical validation study completion delayed	28/09/23
LungLife AI outlook upbeat as interim loss narrows	08/08/23
Earnings Flash (LLAI.L) LUNGLIFE AI Posts H1 Revenue $23,000	08/08/23
Earnings Flash (LLAI.L) LUNGLIFE AI Reports H1 Loss $-0.11	08/08/23
LungLife AI, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	08/08/23
LungLife celebrates publication of LungLB results in journal	06/06/23
LungLife celebrates as it completes enrolment for LungLB test study	23/05/23

Aucun résultat pour cette recherche